⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for secondary raynaud's phenomenon

Every month we try and update this database with for secondary raynaud's phenomenon cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic SclerosisNCT02228850
Raynaud's Pheno...
Alprostadil
Placebo
18 Years - 79 YearsNexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)
Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic SclerosisNCT02228850
Raynaud's Pheno...
Alprostadil
Placebo
18 Years - 79 YearsNexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)
Safety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's PhenomenonNCT02356809
Secondary Rayna...
Neovasculgen
18 Years - 65 YearsHuman Stem Cell Institute, Russia
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: